Syndax Pharmaceuticals, Inc. SNDX
13.10 USD -0.55 -4.03%
At close · Nov 2
13.08 -0.02 -0.15%
After hours · Nov 2, 5:49 PM ET
12.80 52-week range 25.59
- YTD
- -37.65%
- 1 year
- -4.38%
- Open
- 13.62
- Prev close
- 13.65
- Mkt cap
- 1.17B
- Vol
- 3.18M
- Avg vol
- 1.96M
- EPS
- -2.52
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 12.90
- High
- 13.75
- Forward P/E
- -17.89
- Beta
- 0.45
- Short ratio
- 8.03
- Inst. own
- 126.78%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 17.18
- 200-d avg
- 20.23
- 1y target
- 37.27
MAX chart
Chart tools
Chart is warming up
The all-time price history for SNDX has not been loaded yet. Try again in a moment.
Altman Z-Score
-1.57 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -6.4×
P/S 10.6×
P/B 28.2×
P/FCF -5.6×
EV/EBITDA -8.1×
EV/Sales 11.8×
FCF Yield -17.8%
Gross Margin 96.0%
Operating Margin -158.4%
Net Margin -165.6%
ROE -441.6%
ROIC -66.6%
ROA -53.9%
Revenue 627.8%
Operating Income 19.6%
EPS (diluted) 11.8%
Free Cash Flow -17.6%
Current Ratio 4.4×
Quick Ratio 4.1×
Debt / Equity 5.4×
Net Debt / EBITDA -0.8×
Interest Coverage -8.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31